STONEPINE CAPITAL, L.P. purchased 2.7% of their position (100K shares) of NOVELION THERAPEUTICS INC. on the open market
Open‑market purchase worth $64.9K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/16/2019ACC: 0001567619-19-019667
10% Owner
Since Sep 2019
+100K
Net shares
Net buyer
$64.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
$0.65
Trade value
$64.90K
% of position
2.7%
10/11/2019
3.70M→3.80M
Total
Net shares
+100K
Net value
$64.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/11/2019 | P · Purchase | +100K | $0.65 | $64.90K | 2.7% | 3.70M | 3.80M |
| Total | +100K | $64.90K | ||||||
Derivative Transactions0
No derivative transactions reported